绝经过渡期间使用52 mg左炔诺孕酮宫内节育器对绝经后影响的妇女观点

IF 1.9 4区 医学 Q3 OBSTETRICS & GYNECOLOGY European Journal of Contraception and Reproductive Health Care Pub Date : 2023-08-01 DOI:10.1080/13625187.2023.2202292
Jacques B E Versailles, Sherly Metelus, Alessandra Peloggia, Montas Laporte, Luis Bahamondes, Cassia Juliato
{"title":"绝经过渡期间使用52 mg左炔诺孕酮宫内节育器对绝经后影响的妇女观点","authors":"Jacques B E Versailles,&nbsp;Sherly Metelus,&nbsp;Alessandra Peloggia,&nbsp;Montas Laporte,&nbsp;Luis Bahamondes,&nbsp;Cassia Juliato","doi":"10.1080/13625187.2023.2202292","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To assess perimenopausal users of 52 mg levonorgestrel intrauterine devices (LNG-IUD) regarding the IUD impact after menopause.</p><p><strong>Material and methods: </strong>a cross-sectional study with users aged 40 and 49 years old, without cognitive impairment that answered a questionnaire regarding worries and benefits after the menopause due to LNG-IUD use.</p><p><strong>Results: </strong>Almost half of 221 users (52.9%) have concerns that LNG-IUD use could influence aspects after menopause, 111 (50.3%) that the post-menopause symptoms get worse and 92 (41.6%) that interfere with recognition of menopausal symptoms.</p><p><strong>Conclusion: </strong>Half of perimenopausal LNG-IUD users expressed concerns about how device use could affect post-menopause symptoms.</p>","PeriodicalId":50491,"journal":{"name":"European Journal of Contraception and Reproductive Health Care","volume":null,"pages":null},"PeriodicalIF":1.9000,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Women's perspectives on impact on the post menopause of use of the 52 mg levonorgestrel intrauterine device during the menopausal transition.\",\"authors\":\"Jacques B E Versailles,&nbsp;Sherly Metelus,&nbsp;Alessandra Peloggia,&nbsp;Montas Laporte,&nbsp;Luis Bahamondes,&nbsp;Cassia Juliato\",\"doi\":\"10.1080/13625187.2023.2202292\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>To assess perimenopausal users of 52 mg levonorgestrel intrauterine devices (LNG-IUD) regarding the IUD impact after menopause.</p><p><strong>Material and methods: </strong>a cross-sectional study with users aged 40 and 49 years old, without cognitive impairment that answered a questionnaire regarding worries and benefits after the menopause due to LNG-IUD use.</p><p><strong>Results: </strong>Almost half of 221 users (52.9%) have concerns that LNG-IUD use could influence aspects after menopause, 111 (50.3%) that the post-menopause symptoms get worse and 92 (41.6%) that interfere with recognition of menopausal symptoms.</p><p><strong>Conclusion: </strong>Half of perimenopausal LNG-IUD users expressed concerns about how device use could affect post-menopause symptoms.</p>\",\"PeriodicalId\":50491,\"journal\":{\"name\":\"European Journal of Contraception and Reproductive Health Care\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2023-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Contraception and Reproductive Health Care\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/13625187.2023.2202292\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Contraception and Reproductive Health Care","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/13625187.2023.2202292","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:评价绝经前后使用52 mg左炔诺孕酮宫内节育器(LNG-IUD)对绝经后宫内节育器的影响。材料和方法:一项横断面研究,年龄在40岁和49岁之间,无认知障碍的使用者回答了关于使用LNG-IUD后绝经后的担忧和益处的问卷。结果:221例使用LNG-IUD的患者中,近半数(52.9%)担心使用LNG-IUD会影响绝经后的各方面,111例(50.3%)担心使用LNG-IUD会加重绝经后症状,92例(41.6%)担心影响对绝经后症状的认识。结论:半数围绝经期lng宫内节育器使用者表达了对节育器使用如何影响绝经后症状的担忧。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Women's perspectives on impact on the post menopause of use of the 52 mg levonorgestrel intrauterine device during the menopausal transition.

Objectives: To assess perimenopausal users of 52 mg levonorgestrel intrauterine devices (LNG-IUD) regarding the IUD impact after menopause.

Material and methods: a cross-sectional study with users aged 40 and 49 years old, without cognitive impairment that answered a questionnaire regarding worries and benefits after the menopause due to LNG-IUD use.

Results: Almost half of 221 users (52.9%) have concerns that LNG-IUD use could influence aspects after menopause, 111 (50.3%) that the post-menopause symptoms get worse and 92 (41.6%) that interfere with recognition of menopausal symptoms.

Conclusion: Half of perimenopausal LNG-IUD users expressed concerns about how device use could affect post-menopause symptoms.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.70
自引率
11.80%
发文量
63
审稿时长
>12 weeks
期刊介绍: The Official Journal of the European Society of Contraception and Reproductive Health, The European Journal of Contraception and Reproductive Health Care publishes original peer-reviewed research papers as well as review papers and other appropriate educational material.
期刊最新文献
A randomised double-blind trial to determine the bleeding profile of the prolonged-release contraceptive dienogest 2 mg/ethinylestradiol 0.02 mg versus an immediate-release formulation of drospirenone 3 mg/ethinylestradiol 0.02 mg. Medical termination of pregnancy: people's expectations and experiences in the Netherlands. Neighbourhood environment and early menarche among adolescent girls of five countries. Postpartum contraception provision across Europe: preliminary findings from a multi country survey. Response to Daungsupawong and Wiwanitkit's Letter to the Editor.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1